Stocks
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -328.7 | -377.7 | -427.4 | -351.7 | -350.9 | -326.8 | ||
| Changes by years, y/y, % | +26% | +15% | +13% | -18% | 0% | +6.1% | |||
Iovance Biotherapeutics. EBITDA US GAAP, bln rub
Iovance Biotherapeutics. EBITDA US GAAP, changes, %
Iovance Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -97.7 | -78.2 | -60.8 | -70.6 | -41.5 | -326.8 | |
| Changes by years, y/y, % | +7% | +0% | -19% | -34% | -58% | |||
| Changes by quarters, q/q, % | -9% | -20% | -22% | +16% | -41% | |||
